References
- DeneckeTBaurADIhmCEvaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumorsEur J Radiol20138210e550e55523891296
- WangYMillerFHChenZEDiffusion-weighted MR imaging of solid and cystic lesions of the pancreasRadiographics2011313E47E6421721197
- JangKMKimSHLeeSJChoiDThe value of gadoxetic acid- enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumorsActa Radiol201455214014823897307
- ItoTSasanoHTanakaMEpidemiological study of gastroen- teropancreatic neuroendocrine tumors in JapanJ Gastroenterol201045223424320058030
- KlimstraDSArnoldRCapellaCNeuroendocrine neoplasms of the pancreasBosmanFTCarneiroFHrubanRHTheiseNDWHO Classification of Tumours of the Digestive SystemLyonInternational Agency for Research on Cancer (IARC)2010322326
- KimDWKimHJKimKWNeuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumourEur Radiol20152551375138325465713
- KulkeMShahMHBensonABNCCN clinical practice guidelines in oncology (NCCN Guidelines1) neuroendocrine tumors. Version 22014
- YaoJCShahMHItoTRAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study GroupEverolimus for advanced pancreatic neuroendocrine tumorsN Engl J Med2011364651452321306238
- RaymondEDahanLRaoulJLSunitinib malate for the treatment of pancreatic neuroendocrine tumorsN Engl J Med2011364650151321306237
- KartalisNMucelliRMSundinARecent developments in imaging of pancreatic neuroendocrine tumorsAnn Gastroenterol201528219320225830417
- RindiGWiedenmannBNeuroendocrine neoplasms of gut and pancreas: new insightsNat Rev Endocrinol2012815464
- TakumiKFukukuraYHigashiMPancreatic neuroendocrine tumors: correlation between the contrast-enhanced computed tomography features and the pathological tumor gradeEur J Radiol20158481436144326022520
- CappelliCBoggiUMazzeoSContrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumoursEur Radiol201525375175925447971
- TomimaruYEguchiHTatsumiMClinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumorsSurgery2015157226927625311263
- KimJHEunHWKimYJHanJKChoiBIStaging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor gradeAbdom Imaging20133851106111423728305
- WangYChenZEYaghmaiVDiffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristicsJ Magn Reson Imaging20113351071107921509863
- HagmannPJonassonLMaederPThiranJPWedeenVJMeuliRUnderstanding diffusion MR imaging techniques: from scalar diffusion- weighted imaging to diffusion tensor imaging and beyondRadiographics200626suppl 1S205S22317050517
- LotfalizadehERonotMWagnerMPrediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imagingEur Radiol Epub2016819
- MorteléKJRochaTCStreeterJLTaylorAJMultimodality imaging of pancreatic and biliary congenital anomaliesRadiographics200626371573116702450
- SadowskiSMNeychevVMilloCProspective Study of 68Ga- DOTATATE positron emission tomography/computed tomography for detecting gastro-enteropancreatic neuroendocrine tumors and unknown primary sitesJ Clin Oncol201634658859626712231
- ItoTHijiokaSMasuiTAdvances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in JapanJ Gastroenterol201752191827539256
- IkedaMOkuyamaHTakahashiHChemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinomaJ Hepatobiliary Pancreat Sci201522862362725755102
- Velayoudom-CephiseFLDuvillardPFoucanLAre G3 ENETS neuroendocrine neoplasms heterogeneous?EndocrRelat Cancer2013205649657
- KimJHLeeJMParkJHSolid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment - a preliminary studyRadiology2013266118519623192779
- SatohKSadowskiSMDieckmannW18F-FDG PET/CT volumetric parameters are associated with tumor grade and metastasis in pancreatic neuroendocrine tumors in von Hippel-Lindau diseaseAnn Surg Oncol201623suppl 571472127638678
- IchikawaTFederleMOhbaSAtypical exocrine and endocrine pancreatic tumors (anaplastic, small cell, and giant cell types): CT and pathologic features in 14 patientsAbdom Imaging200025440941910926196
- BettiniRPartelliSBoninsegnaLTumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumorSurgery20111501758221683859
- ChoMYSohnJHJinSYProposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters. Gastrointestinal Pathology Study Group of Korean Society of PathologistsKorean J Pathol201347322723723837015
- PadhaniARLiuGKohDMDiffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendationsNeoplasia200911210212519186405
- HiganoSYunXKumabeTMalignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosisRadiology2006241383984617032910
- BrennerRMetensTBaliMDemetterPMatosCPancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detectionEur J Radiol2012815e746e74922386133
- CaramellaCDromainCDe BaereTEndocrine pancreatic tumours: which are the most useful MRI sequences?Eur Radiol201020112618262720668861
- DonatiOFChongDNanzDDiffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficientsRadiology2014270245446324471390